Injury, dysbiosis and filaggrin deficiency drive skin inflammation via keratinocyte IL-1α release
Our data demonstrate that injury and dysbiosis drive intracellular IL-1α release from keratinocytes to mediate chronic inflammation in filaggrin-deficient mice. IL-1α and dysbiosis could represent therapeutic targets to reduce skin inflammation in atopic dermatitis.
Saved in:
Published in | Journal of allergy and clinical immunology Vol. 143; no. 4; pp. 1426 - 1443.e6 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
19.09.2018
|
Online Access | Get full text |
Cover
Loading…
Abstract | Our data demonstrate that injury and dysbiosis drive intracellular IL-1α release from keratinocytes to mediate chronic inflammation in filaggrin-deficient mice. IL-1α and dysbiosis could represent therapeutic targets to reduce skin inflammation in atopic dermatitis. |
---|---|
AbstractList | Our data demonstrate that injury and dysbiosis drive intracellular IL-1α release from keratinocytes to mediate chronic inflammation in filaggrin-deficient mice. IL-1α and dysbiosis could represent therapeutic targets to reduce skin inflammation in atopic dermatitis. |
Author | Oyoshi, Michiko Marchitto, Mark C. Wang, Yu Liu, Haiyun Geha, Raif S. Ashbaugh, Alyssa G. Archer, Nathan K. Ravipati, Advaitaa Smith, Barbara Hoff, Sabine Lee, Steven K. Ortines, Roger V. Malhotra, Nidhi Miller, Lloyd S. Dillen, Carly A. Jo, Jay-Hyun Kim, Dongwon Miller, Robert J. Cai, Shuting S. Uppal, Angad S. Garza, Luis A Kong, Heidi H. Segre, Julia A. |
AuthorAffiliation | 1 Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA 8 Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA 3 Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA 7 Department of Medicine, Division of Infectious Diseases 4 Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA 9 Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA 2 Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA 5 TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany 6 Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA |
AuthorAffiliation_xml | – name: 2 Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA – name: 8 Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA – name: 5 TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany – name: 7 Department of Medicine, Division of Infectious Diseases – name: 3 Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA – name: 1 Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA – name: 4 Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA – name: 9 Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – name: 6 Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA |
Author_xml | – sequence: 1 givenname: Nathan K. surname: Archer fullname: Archer, Nathan K. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 2 givenname: Jay-Hyun surname: Jo fullname: Jo, Jay-Hyun organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 3 givenname: Steven K. surname: Lee fullname: Lee, Steven K. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 4 givenname: Dongwon surname: Kim fullname: Kim, Dongwon organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 5 givenname: Barbara surname: Smith fullname: Smith, Barbara organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 6 givenname: Roger V. surname: Ortines fullname: Ortines, Roger V. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 7 givenname: Yu surname: Wang fullname: Wang, Yu organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 8 givenname: Mark C. surname: Marchitto fullname: Marchitto, Mark C. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 9 givenname: Advaitaa surname: Ravipati fullname: Ravipati, Advaitaa organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 10 givenname: Shuting S. surname: Cai fullname: Cai, Shuting S. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 11 givenname: Carly A. surname: Dillen fullname: Dillen, Carly A. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 12 givenname: Haiyun surname: Liu fullname: Liu, Haiyun organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 13 givenname: Robert J. surname: Miller fullname: Miller, Robert J. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 14 givenname: Alyssa G. surname: Ashbaugh fullname: Ashbaugh, Alyssa G. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 15 givenname: Angad S. surname: Uppal fullname: Uppal, Angad S. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 16 givenname: Michiko surname: Oyoshi fullname: Oyoshi, Michiko organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 17 givenname: Nidhi surname: Malhotra fullname: Malhotra, Nidhi organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 18 givenname: Sabine surname: Hoff fullname: Hoff, Sabine organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 19 givenname: Luis A surname: Garza fullname: Garza, Luis A organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 20 givenname: Heidi H. surname: Kong fullname: Kong, Heidi H. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 21 givenname: Julia A. surname: Segre fullname: Segre, Julia A. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 22 givenname: Raif S. surname: Geha fullname: Geha, Raif S. organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA – sequence: 23 givenname: Lloyd S. surname: Miller fullname: Miller, Lloyd S. email: lloydmiller@jhmi.edu organization: Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA Dermatology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Division of Immunology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, MA, USA TRG Oncology III, Drug Discovery, Bayer AG, Berlin, Germany Microbial Genomics Section, Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA Department of Medicine, Division of Infectious Diseases, Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA Department of Materials Science and Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA |
BookMark | eNqljE1KxEAQhRsZcWbUC7jqA5jY3fnfuBHFAZfuQyWpxMok1UN3JpBjeRHPZBZuXA88eHzfg7cXG7aMQjxoFWql06c-7KGm0Cidh2pNbK7ETqsiC9LcJBuxU6rQQZrFxVbsve_VylFe3IhtpEysMmV2ojpwf3bLo2wWX5H15CVwI1saoOscsWywpZqQ60U2jmaU_rha4naAcYSJLMuZQB7RrcC2XiaUh49A_3xLhwOCxztx3cLg8f6vb8Xz2-vny3twOlcjNjXy5GAoT45GcEtpgcr_C9NX2dm5TGMTp0kSXXzwC0XXaKU |
ContentType | Journal Article |
DBID | 5PM |
DOI | 10.1016/j.jaci.2018.08.042 |
DatabaseName | PubMed Central (Full Participant titles) |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1097-6825 |
EndPage | 1443.e6 |
GroupedDBID | --- --K --M -~X .1- .FO .XZ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 354 3V. 4.4 457 4G. 53G 5GY 5PM 5RE 5VS 7-5 71M 7RV 7X7 8C1 8FE 8FH 8P~ 9JM AAAJQ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AARKO AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABOCM ACDAQ ACGFO ACGFS ACPRK ACRLP ADBBV ADEZE ADFRT AEBSH AEKER AENEX AFKRA AFKWA AFRAH AFRHN AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AHHHB AHMBA AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BBNVY BENPR BHPHI BKOJK BLXMC BNPGV BPHCQ BVXVI C45 CJTIS CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 EX3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA HCIFZ HMK IHE J1W J5H K-O KOM L7B LK8 LUGTX M27 M2O M41 M7P MO0 N9A O-L O9- O9~ OAUVE OBH ODZKP OHH OK0 OK1 OVD OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 RIG ROL RPZ SCC SDF SDG SDP SEL SES SJN SPCBC SSH SSI SSZ T5K TEORI TWZ UGJ UNMZH UV1 WH7 WOW XFW YOC Z5R ZY1 ~02 ~G- ~KM |
ID | FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_64246553 |
ISSN | 0091-6749 |
IngestDate | Tue Sep 17 20:30:51 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-pubmedcentral_primary_oai_pubmedcentral_nih_gov_64246553 |
Notes | Author contributions: N.K.A., L.A.G., H.H.K., J.A.S., R.S.G. and L.S.M. designed research; N.K.A., J-H.J., S.K.L., D.K., B.S., R.V.O., Y.W., M.C.M., A.R., S.S.C., C.A.D., H.L., R.J.M., A.G.A., A.S.U., M.O., N.M. and S.H. performed research; L.A.G., J-H.J., H.H.K., J.A.S., R.S.G. contributed new reagents/analytic tools; N.K.A., J-H.J., L.A.G., H.H.K., J.A.S., R.S.G. and L.S.M. analyzed data; and N.K.A., H.H.K., J.A.S., R.S.G. and L.S.M. wrote the paper. Author contributions |
PMID | 30240702 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6424655 |
PublicationCentury | 2000 |
PublicationDate | 20180919 |
PublicationDateYYYYMMDD | 2018-09-19 |
PublicationDate_xml | – month: 9 year: 2018 text: 20180919 day: 19 |
PublicationDecade | 2010 |
PublicationTitle | Journal of allergy and clinical immunology |
PublicationYear | 2018 |
SSID | ssj0009389 |
Score | 4.6260033 |
Snippet | Our data demonstrate that injury and dysbiosis drive intracellular IL-1α release from keratinocytes to mediate chronic inflammation in filaggrin-deficient... |
SourceID | pubmedcentral |
SourceType | Open Access Repository |
StartPage | 1426 |
Title | Injury, dysbiosis and filaggrin deficiency drive skin inflammation via keratinocyte IL-1α release |
URI | https://pubmed.ncbi.nlm.nih.gov/PMC6424655 |
Volume | 143 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LT-pAFMcnqIlxY9Sr8Z1Z6AqnoaXPjYmiBvViXHgTd2baDljUYhA0uPADufOL-Jk8Z2ZoC7q4smlIeQxwfjnz-p__ELJjNQNh-X7MYpNzZjtNzqBfdxhKGZ24wn1P7pg2Ltz6P_vs2rkuld4LqqV-LzSi1x_rSiaJKtyDuGKV7C8im30o3IDHEF-4QoTh-l8xPk3behs8HjyFSQfNRXAhvJnc81arK4Wu6BAhyyvjLoqEnu4S1DY2AQRVtFh-Tnj5Dq2Vk7QTDXqifPqXmbu1491DU56oMty--T6CxWNYutrAKauwTLDgZGStHs1tFRgXcqG-fG7kuh2l1B2w-qA_Lg5SB64VXq1Pfj7qpK0XTZNerzCluEJnRZ2DA5O5njIqNYRKu5XAY66vSqCzvKz8mzSAdiHLmrblFnpsmBNWDeH-2CGotYm20eZRgkI-Xxq2KkOvAiGPDxKRKjq-eRUr7xyHgoDLRg1mamg2N0VmLEhqmE2Nt1xOFFR9NdXSv04XaCkt4Xjrc2R22NS4GLcwurlaIPM6qPRAMbZISiJdIrMNLbz4Q0KF2h7NQKMQdZqBRnPQqASNImi0CBoF0GgRNIqgfX5QDdky2T85vqrV2cgXvXlUdig3aFA--kya3Eqjcv2PVVfIdNpJxSqhMP60fTuMYBLt2LEtAi9wOLdE4IZW5MV8jXgTNrI-8Ts3yFzO6SaZ7nX7YgtGmr1wW4b4C-IwiY4 |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Injury%2C+dysbiosis+and+filaggrin+deficiency+drive+skin+inflammation+via+keratinocyte+IL-1%CE%B1+release&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Archer%2C+Nathan+K.&rft.au=Jo%2C+Jay-Hyun&rft.au=Lee%2C+Steven+K.&rft.au=Kim%2C+Dongwon&rft.date=2018-09-19&rft.issn=0091-6749&rft.eissn=1097-6825&rft.volume=143&rft.issue=4&rft.spage=1426&rft.epage=1443.e6&rft_id=info:doi/10.1016%2Fj.jaci.2018.08.042&rft_id=info%3Apmid%2F30240702&rft.externalDBID=PMC6424655 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon |